Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: Antagonism by anandamide

Molecular Pharmacology

Volumn 57, Issue 5, 2000, Pages 1045-1050

  Gonsiorek, Waldemar ^a   Lunn, Charles ^a   Fan, Xuedong ^a   Narula, Satwant ^a   Lundell, Daniel ^a   Hipkin, R William ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONYL GLYCEROL; ANANDAMIDE; CANNABINOID DERIVATIVE; CANNABINOID RECEPTOR; COMPLEMENTARY DNA; CYCLIC AMP; DEXANABINOL; GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL PROLIFERATION; CHO CELL; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENCY; ENZYME IMMUNOASSAY; IMMUNOCOMPETENT CELL; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ARACHIDONIC ACIDS; BINDING, COMPETITIVE; CALCIUM CHANNEL BLOCKERS; CANNABINOIDS; CELL MEMBRANE; CHO CELLS; CRICETINAE; CYCLIC AMP; CYCLOHEXANOLS; DRUG ANTAGONISM; ENDOCANNABINOIDS; FORSKOLIN; GLYCERIDES; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; IMMUNOSUPPRESSIVE AGENTS; INSECTS; POLYUNSATURATED ALKAMIDES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SULFUR RADIOISOTOPES; TRANSFECTION;

EID: 0034058250     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Bayewitch M, Avidor-Reiss T, Levy R, Barg J, Mechoulam R and Vogel Z (1995) The peripheral cannabinoid receptor: Adenylate cyclase inhibition and G protein coupling. FEBS Lett 375:143-147.
2. Bouaboula M, Poinot-Chazel C, Bourrie B, Canat X, Calandra B, Rinaldi-Carmona M, Le Fur G and Casellas P (1995) Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. Biochem J 312:637-641.
3. Bouaboula M, Poinot-Chazel C, Marchand J, Canat X, Bourrie B, Rinaldi-Carmona M, Calandra B, Le Fur G and Casellas P (1996) Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression. Eur J Biochem 237:704-711.
4. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
5. Cabral GA, Toney DM, Fischer-Stenger K, Harrison MP and Marciano-Cabral F (1995) Anandamide inhibits macrophage-mediated killing of tumor necrosis factor-sensitive cells. Life Sci 56:2065-2072.
6. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
7. Compton DR and Martin BR (1997) The effect of the enzyme inhibitor phenylmethylsulfonyl fluoride on the pharmacological effect of anandamide in the mouse model of cannabimimetic activity. J Pharmacol Exp Ther 283:1138-1143.
8. Derocq JM, Bouaboula M, Marchand J, Rinaldi-Carmona M, Segui M and Casellas P (1998) The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines. FEBS Lett 425:419-425.
9. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A and Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science (Wash DC) 258:1946-1949.
10. Di Marzo V, Bisogno T, De Petrocellis L, Melck D, Orlando P, Wagner JA and Kunos G (1999) Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. Eur J Biochem 264:258-267.
11. Facci L, Dal Toso R, Romanello S, Buriani A, Skaper SD and Leon A (1995) Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci USA 92:3376-3380.
12. Felder CC, Joyce KE, Briley EM, Glass M, Mackie KP, Fahey KJ, Cullinan GJ, Hunden DC, Johnson DW, Chaney MO, Koppel GA and Brownstein M (1998) LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation. J Pharmacol Exp Ther 284: 291-297.
13. Galiegue S, Mary S, Marchand J, Dussossoy D, Carriere D, Carayon P, Bouaboula M, Shire D, Le Fur G and Casellas P (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 232:54-61.
14. Gerard CM, Mollereau C, Vassart G and Parmentier M (1991) Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem J 279: 129-134.
15. Glass M and Felder CC (1997) Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: Evidence for a Gs linkage to the CB1 receptor. J Neurosci 17:5327-5333.
16. Goparaju SK, Ueda N, Yamaguchi H and Yamamoto S (1998) Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand. FEBS Lett 422:69-73.
17. Hillard CJ, Edgemond WS and Campbell WB (1995) Characterization of ligand binding to the cannabinoid receptor of rat brain membranes using a novel method: Application to anandamide. J Neurochem 64:677-683.
18. Hipkin RW, Friedman J, Clark RB, Eppler CM and Schonbrunn A (1997) Agonist-induced desensitization, internalization, and phosphorylation of the sst2A somatostatin receptor. J Biol Chem 272:13869-13876.
19. Kaminski NE (1996) Immune regulation by cannabinoid compounds through the inhibition of the cyclic AMP signaling cascade and altered gene expression. Biochem Pharmacol 52:1133-1140.
20. Kaminski NE (1998) Regulation of the cAMP cascade, gene expression and immune function by cannabinoid receptors. J Neuroimmunol 83:124-132.
21. Kaminski NE, Abood ME, Kessler FK, Martin BE and Schatz AR (1992) Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation. Mol Pharmacol 42:736-742.
22. Klein TW, Newton C and Friedman H (1998) Cannabinoid receptors and the cytokine network. Adv Exp Med Biol 437:215-222.
23. Krumins AM and Barber R (1997) Examination of the effects of increasing Gs protein on beta2-adrenergic receptor, Gs, and adenylyl cyclase interactions. Biochem Pharmacol 54:61-72.
24. Lee M, Yang KH and Kaminski NE (1995) Effects of putative cannabinoid receptor ligands, anandamide and 2- arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes. J Pharmacol Exp Ther 275:529-536.
25. Mackie K and Hille B (1992) Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc Natl Acad Sci USA 89:3825-3829.
26. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC and Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature (Lond) 346:561-564.
27. Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR, Pertwee RG, Griffin G, Bayewitch M, Barg J and Vogel Z (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50:83-90.
28. Munro S, Thomas KL and Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature (Lond) 365:61-65.
29. Ouyang Y, Hwang SG, Han SH and Kaminski NE (1998) Suppression of interleukin-2 by the putative endogenous cannabinoid 2- arachidonyl-glycerol is mediated through down-regulation of the nuclear factor of activated T cells. Mol Pharmacol 53:676-683.
30. Pertwee RG (1997) Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 74:129-180.
31. Pertwee RG, Fernando SR, Griffin G, Abadji V and Makriyannis A (1995) Effect of phenylmethylsulphonyl fluoride on the potency of anandamide as an inhibitor of electrically evoked contractions in two isolated tissue preparations. Eur J Pharmacol 272:73-78.
32. Schatz AR, Lee M, Condie RB, Pulaski JT and Kaminski NE (1997) Cannabinoid receptors CB1 and CB2: A characterization of expression and adenylate cyclase modulation within the immune system. Toxicol Appl Pharmacol 142:278-287.
33. Slipetz DM, O'Neill GP, Favreau L, Dufresne C, Gallant M, Gareau Y, Guay D, Labelle M and Metters KM (1995) Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase. Mol Pharmacol 48:352-361.
34. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A and Waku K (1995) 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215:89-97.
35. Valk P, Verbakel S, Vankan Y, Hol S, Mancham S, Ploemacher R, Mayen A, Lowenberg B and Delwel R (1997) Anandamide, a natural ligand for the peripheral cannabinoid receptor is a novel synergistic growth factor for hematopoietic cells. Blood 90:1448-1457.
36. Whaley BS, Yuan N, Birnbaumer L, Clark RB and Barber R (1994) Differential expression of the beta-adrenergic receptor modifies agonist stimulation of adenylyl cyclase: A quantitative evaluation. Mol Pharmacol 45:481-489.